Browse studies

Find your next paid study

27,293 recruiting studies available now

A Phase 1a/b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of PRMT5 Inhibitor BGB-58067 Alone and in Combination With Anticancer Agents in Patients With Advanced Solid Tumors

This is an open-label, multicenter, first-in-human dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodyn…

Advanced Solid Tumor

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BeOne MedicinesNCT06589596

Observational

Virtual Reality Implementation for Pain and Anxiety Management During Intra-articular Glucocorticoid Injections in a Pediatric Rheumatology Clinic

The goal of the project is to implement virtual reality for pain and anxiety management for patients undergoing intra-articular glucocorticoid injections in th…

Acute PainProcedural AnxietyJuvenile Idiopahtic Arthritis

Estimated

~$10 – $750

Actual pay is set by the research site.

Nationwide Children's HospitalNCT07778069

Phase 3

Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults With Angelman Syndrome Due to Paternal Uniparental Disomy or Imprinting Defects

The primary purpose of the study is to evaluate efficacy of obudanersen in participants with AS due to uniparental disomy or imprinting defects (UPD/ID) as mea…

Angelman Syndrome

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Ionis Pharmaceuticals, Inc.NCT07782827

Phase 3

A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adults With COVID-19 at High Risk for Disease Progression

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symptoms. Howe…

Coronavirus Disease (COVID-19)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT06667700

Phase 2

Pembrolizumab and GVD With ctDNA-guided Consolidation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium

This is a single arm, open-label, multicenter, phase II study of pembrolizumab (pembro), gemcitabine, vinorelbine, and liposomal doxorubicin (GVD) in patients …

Hodgkin Lymphoma, AdultRefractory Hodgkin LymphomaClassic Hodgkin Lymphoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Michael Spinner, MDNCT07021989

Observational

Post Marketing Data Collection on Use of ProSense® Cryoablation System With Adjuvant Endocrine Therapy for the Treatment of Patients With Low-Risk, Early-Stage Breast Cancer (ChoICE Trial)

The FDA has granted marketing authorization for the ProSense® Cryoablation System for the local treatment of patients aged 70 years or older with low-risk earl…

Low-Risk, Early Stage Breast Cancer

Estimated

~$10 – $1,050

Actual pay is set by the research site.

IceCure Medical Ltd.NCT07629206

Observational

Self-Concept Reinforcement for Early School Readiness: Pilot Randomized Controlled Trial of a Clinic-Based Intervention for Young African American Children

The goal of this pilot randomized controlled trial is to evaluate a self-concept intervention (Self-Concept Reinforcement for Early School Readiness (SCR4ESR))…

Child BehaviorChild Behavior ProblemChild Behavior Disorders

Estimated

~$10 – $750

Actual pay is set by the research site.

Children's Hospital Los AngelesNCT06084910

Phase 2

Ketamine for the Treatment of Opioid Use Disorder

The goal of this clinical trial is to learn if ketamine works to reduce craving for opioids in adults enrolled in methadone treatment for opioid use disorder. …

Opioid Use Disorder

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of Maryland, BaltimoreNCT06943859

Phase 2

A Randomized Phase II Trial of Sacituzumab Govitecan-HZIY (SG) and Bevacizumab Versus Standard of Care Carboplatin, Pegylated Liposomal Doxorubicin (PLD) and Bevacizumab in Patients With Platinum-Sensitive Ovarian Cancer That Has Progressed on Prior Maintenance PARP Inhibitor Therapy

This phase II trial compares the effect of sacituzumab govitecan and bevacizumab to standard care (carboplatin, pegylated liposomal doxorubicin, and bevacizuma…

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid AdenocarcinomaRecurrent Platinum-Sensitive Fallopian Tube High Grade Serous AdenocarcinomaRecurrent Platinum-Sensitive Ovarian High Grade Endometrioid Adenocarcinoma+3 more

Estimated

~$75 – $1,800

Phase 3

A Phase 3, Multiregional, Open-label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide in Participants With Relapsed/Refractory Primary Central Nervous System Lymphoma (IGNITE)

The purpose of this clinical trial is to evaluate efficacy and safety of tirabrutinib alone compared with rituximab and temozolomide (R-TMZ) combination therap…

Relapsed/Refractory Primary Central Nervous System Lymphoma

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Ono Pharmaceutical Co., Ltd.NCT07104032

Observational

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

The purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI

Urge Urinary Incontinence

Estimated

~$10 – $1,125

Actual pay is set by the research site.

MedtronicNeuroNCT07456865

Observational

Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population

The goal of this clinical trial is to learn if the Gixam device effectively identifies persons with pre-cancer or cancer in the colon and rectum in adults aged…

CRC ScreeningMicrobiome

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Jubaan Ltd.NCT07623902